EXAGEN INC. (XGN) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $24.00K; Additional Paid in CapitalUSD $333.64M; Retained Earnings (Accumulated Deficit)USD $-321.44M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $24.00K; Additional Paid in CapitalUSD $332.66M; Retained Earnings (Accumulated Deficit)USD $-318.25M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $23.00K; Additional Paid in CapitalUSD $331.71M; Retained Earnings (Accumulated Deficit)USD $-314.28M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $23.00K; Additional Paid in CapitalUSD $327.72M; Retained Earnings (Accumulated Deficit)USD $-309.61M.
EXAGEN INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $24.00K | $333.64M | $-321.44M | $12.22M | 3 month · $980.00K | (m) |
| 2026-03-31 | $0.00 | $24.00K | $332.66M | $-318.25M | $14.43M | 3 month · $655.00K | (m) |
| 2025-12-31 | $0.00 | $23.00K | $331.71M | $-314.28M | $17.45M | 12 month · $2.16M | (m) |
| 2025-09-30 | $0.00 | $23.00K | $327.72M | $-309.61M | $18.14M | 3 month · $593.00K | (m) |
| 2025-06-30 | $0.00 | $22.00K | $323.53M | $-302.52M | $21.03M | 3 month · $443.00K | (m) |
| 2025-03-31 | $0.00 | $18.00K | $304.47M | $-298.08M | $6.40M | 3 month · $417.00K | (m) |
| 2024-12-31 | $0.00 | $18.00K | $303.85M | $-294.33M | $9.54M | 12 month · $1.76M | (m) |
| 2024-09-30 | $0.00 | $18.00K | $303.42M | $-290.57M | $12.87M | 3 month · $217.00K | (m) |
| 2024-06-30 | $0.00 | $17.00K | $303.11M | $-285.54M | $17.59M | 3 month · $560.00K | (m) |
| 2024-03-31 | $0.00 | $17.00K | $302.55M | $-282.58M | $19.99M | 3 month · $553.00K | (m) |
| 2023-12-31 | $0.00 | $17.00K | $301.89M | $-279.22M | $22.69M | 12 month · $3.62M | (m) |
| 2023-09-30 | $0.00 | $17.00K | $301.13M | $-273.64M | $27.50M | 3 month · $890.00K | (m) |
| 2023-06-30 | $0.00 | $17.00K | $300.11M | $-268.23M | $31.90M | 3 month · $978.00K | (m) |
| 2023-03-31 | $0.00 | $17.00K | $299.13M | $-263.21M | $35.94M | 3 month · $986.00K | (m) |
| 2022-12-31 | $0.00 | $17.00K | $297.97M | $-255.53M | $42.46M | 12 month · $4.70M | (m) |
| 2022-09-30 | $0.00 | $16.00K | $297.34M | $-241.17M | $56.19M | 3 month · $1.31M | (m) |
| 2022-06-30 | $0.00 | $16.00K | $295.88M | $-233.08M | $62.82M | 3 month · $1.44M | (m) |
| 2022-03-31 | $0.00 | $16.00K | $294.55M | $-218.41M | $76.16M | 3 month · $1.38M | (m) |
| 2021-12-31 | $0.00 | $16.00K | $293.06M | $-208.14M | $84.94M | 12 month · $4.73M | 12 month · $12.78M |
| 2021-09-30 | $0.00 | $16.00K | $291.87M | $-201.09M | $90.80M | 3 month · $1.35M | (m) |
| 2021-06-30 | $0.00 | $16.00K | $290.27M | $-193.91M | $96.38M | 3 month · $1.28M | 3 month · $12.78M |
| 2021-03-31 | $0.00 | $17.00K | $288.95M | $-187.50M | $101.47M | 3 month · $912.00K | (m) |
| 2020-12-31 | $0.00 | $13.00K | $223.12M | $-181.29M | $41.84M | 12 month · $2.69M | (m) |
| 2020-09-30 | $0.00 | $13.00K | $222.30M | $-177.84M | $44.47M | 3 month · $799.00K | (m) |
| 2020-06-30 | $0.00 | $13.00K | $221.36M | $-173.53M | $47.84M | 3 month · $647.00K | (m) |
| 2020-03-31 | $0.00 | $13.00K | $220.69M | $-170.16M | $50.54M | 3 month · $431.00K | (m) |
| 2019-12-31 | $0.00 | $13.00K | $220.25M | $-164.60M | $55.66M | 12 month · $572.00K | (m) |
| 2019-09-30 | $0.00 | $13.00K | $219.83M | $-161.19M | $58.65M | 3 month · $62.00K | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | $-121.73M | 3 month · $11.00K | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | $-116.77M | 3 month · $12.00K | (m) |
| 2018-12-31 | $0.00 | $0.00 | $40.60M | $-152.56M | $-111.97M | 12 month · $114.00K | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | $-107.81M | 3 month · $10.00K | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | $-103.29M | 3 month · $44.00K | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | $-98.88M | 3 month · $46.00K | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | $-96.68M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |